Medline Inc. MDLN

Annual Quarterly

FY2025 · ended Dec 31, 2025 · Revenue $28.43B · Filed Feb 25, 2026

Medline Inc. (MDLN) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $28.4 billion and net income of $1.2 billion. Free cash flow was $1.3 billion. As of Sep 26, 2026 it held $3.6 billion in cash and investments and $12.6 billion in total debt.

Revenue
$28.43B
Net income
$1.16B
Operating cash flow
$1.74B
Free cash flow
$1.30B
EPS
$-0.01
Dividend per share
None
Shares outstanding
—
Net cash
$-9.04B
as of Sep 26, 2026
Operating margin
7.8%
FY 2025

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
MDLN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Northfield, IL
SEC filer status
Non-accelerated filer
SEC CIK
2046386

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

FY 2025
Dec 31, 2025
Revenue
$28.4B
Operating income
$2.2B
Net income
$1.2B
Diluted EPS
-$0.01
Operating cash flow
$1.7B
Free cash flow
$1.3B
Total assets
$38.5B
Total liabilities
$19.2B
Stockholders' equity
$10.7B
Cash and investments
$1.9B
Total debt
$13.0B

Recent SEC filings

Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 26, 2026
8-K Current report
Results of operations
 Nov 4, 2026 Nov 4, 2026
8-K Current report
Regulation FD disclosure
 Oct 21, 2026 Oct 21, 2026
8-K Current report
Officer or director change
 Oct 15, 2026 Oct 13, 2026
10-Q Quarterly report Aug 5, 2026 Jun 27, 2026
8-K Current report
Results of operations
 Aug 5, 2026 Aug 5, 2026

All 158 Medline Inc. SEC filings

Source: SEC EDGAR filings. This is company-reported data, not investment advice.